Kiora Pharmaceuticals Mergers & Acquisitions

Kiora Pharmaceuticals M&A Summary

Kiora Pharmaceuticals has acquired 3 companies, including 2 in the last 5 years.

Kiora Pharmaceuticals has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 2

Kiora Pharmaceuticals

Kiora Pharmaceuticals, Inc.

332 Encinitas Boulevard Suite 102,
Encinitas, California 92024
United States,
(858) 224-9600
www.kiorapharma.com

All (3) Buy (3) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2021-07-26 Bayon · Life Science
San Diego, California · www.bayontx.com

Bayon is an ophthalmic specialty pharmaceutical company focused on developing light sensitive small molecules. These photoswitches are specifically designed to restore the eyes’ ability to perceive and interpret vision in visually-impaired patients. Bayon’s lead candidate, a small molecule known as “BENAQ”, selectively enters viable downstream retinal ganglion cells (no longer receiving input from degenerated rods and cones) and turns them into light sensing cells, capable of signaling the brain as to the presence or absence of light. BENAQ, the company’s lead photoswitch, is entering the clinic with an initial focus in patients with later stages of disease progression due to Retinitis Pigmentosa (all sub-forms). Bayon plans to further develop the platform for use in patients with Geographic Atrophy, the later stages of Age-Related Macular Degeneration (dry AMD).

- Add-on Acquisition

Kiora Pharmaceuticals

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.